• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌细胞中血管紧张素 -(1 - 7)介导的信号传导

Angiotensin-(1-7)-mediated signaling in cardiomyocytes.

作者信息

Gomes Enéas R M, Santos Robson A S, Guatimosim Silvia

机构信息

Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, 31270-901 Belo Horizonte, MG, Brazil.

出版信息

Int J Hypertens. 2012;2012:493129. doi: 10.1155/2012/493129. Epub 2012 Mar 4.

DOI:10.1155/2012/493129
PMID:22518286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3303610/
Abstract

The Renin-Angiotensin System (RAS) acts at multiple targets and has its synthesis machinery present in different tissues, including the heart. Actually, it is well known that besides Ang II, the RAS has other active peptides. Of particular interest is the heptapeptide Ang-(1-7) that has been shown to exert cardioprotective effects. In this way, great compilations about Ang-(1-7) actions in the heart have been presented in the literature. However, much less information is available concerning the Ang-(1-7) actions directly in cardiomyocytes. In this paper, we show the actual knowledge about Ang-(1-7)-mediated signaling in cardiac cells more specifically we provide a brief overview of ACE2/Ang-(1-7)/Mas axis; and highlight the discoveries made in cardiomyocyte physiology through the use of genetic approaches. Finally, we discuss the protective signaling induced by Ang-(1-7) in cardiomyocytes and point molecular determinants of these effects.

摘要

肾素-血管紧张素系统(RAS)作用于多个靶点,其合成机制存在于包括心脏在内的不同组织中。实际上,众所周知,除了血管紧张素II(Ang II)外,RAS还有其他活性肽。特别值得关注的是七肽Ang-(1-7),它已被证明具有心脏保护作用。通过这种方式,文献中已经出现了关于Ang-(1-7)在心脏中作用的大量综述。然而,关于Ang-(1-7)直接在心肌细胞中的作用的信息却少得多。在本文中,我们更具体地展示了关于Ang-(1-7)介导的心脏细胞信号传导的实际知识,我们简要概述了ACE2/Ang-(1-7)/Mas轴;并强调了通过使用基因方法在心肌细胞生理学中取得的发现。最后,我们讨论了Ang-(1-7)在心肌细胞中诱导的保护信号,并指出这些作用的分子决定因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/3303610/40d96b8ab788/IJHT2012-493129.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/3303610/b384c2ccf4a9/IJHT2012-493129.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/3303610/8d84cd5054d7/IJHT2012-493129.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/3303610/b3009eb2f445/IJHT2012-493129.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/3303610/40d96b8ab788/IJHT2012-493129.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/3303610/b384c2ccf4a9/IJHT2012-493129.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/3303610/8d84cd5054d7/IJHT2012-493129.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/3303610/b3009eb2f445/IJHT2012-493129.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ce8/3303610/40d96b8ab788/IJHT2012-493129.004.jpg

相似文献

1
Angiotensin-(1-7)-mediated signaling in cardiomyocytes.心肌细胞中血管紧张素 -(1 - 7)介导的信号传导
Int J Hypertens. 2012;2012:493129. doi: 10.1155/2012/493129. Epub 2012 Mar 4.
2
Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.肝脏疾病与肾素-血管紧张素系统:最新发现及临床意义
J Gastroenterol Hepatol. 2008 Sep;23(9):1327-38. doi: 10.1111/j.1440-1746.2008.05461.x. Epub 2008 Jun 28.
3
Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.阿拉曼丁通过 MrgD 诱导 AMPK/NO 激活,对抗心肌细胞中 ANG II 引起的肥大。
Am J Physiol Cell Physiol. 2018 Jun 1;314(6):C702-C711. doi: 10.1152/ajpcell.00153.2017. Epub 2018 Feb 14.
4
New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.基于血管紧张素转换酶2/血管紧张素-(1-7)/mas受体轴的新型心血管和肺部治疗策略
Int J Hypertens. 2012;2012:147825. doi: 10.1155/2012/147825. Epub 2012 Jan 26.
5
Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney.肾脏中的血管紧张素转换酶2、血管紧张素-(1-7)和MAS受体轴
Int J Hypertens. 2012;2012:414128. doi: 10.1155/2012/414128. Epub 2012 Feb 8.
6
Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.血管紧张素转换酶 2、血管紧张素-(1-7)和 Mas:肾素-血管紧张素系统的新成员。
J Endocrinol. 2013 Jan 18;216(2):R1-R17. doi: 10.1530/JOE-12-0341. Print 2013 Feb.
7
Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.肾素-血管紧张素系统中的魔鬼与天使:ACE-血管紧张素II-AT1受体轴与ACE2-血管紧张素-(1-7)-Mas受体轴
Hypertens Res. 2009 Jul;32(7):533-6. doi: 10.1038/hr.2009.74. Epub 2009 May 22.
8
Angiotensin-(1-7): beyond the cardio-renal actions.血管紧张素-(1-7):超越心肾作用。
Clin Sci (Lond). 2013 Apr;124(7):443-56. doi: 10.1042/CS20120461.
9
Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure.靶向心脏成纤维细胞中的 ACE2-Ang-(1-7) 途径治疗心肌重构和心力衰竭。
J Mol Cell Cardiol. 2011 Oct;51(4):542-7. doi: 10.1016/j.yjmcc.2010.12.003. Epub 2010 Dec 13.
10
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.血管紧张素转换酶2与血管活性肽:心血管/肾脏重塑及高血压中的新角色
Ther Adv Cardiovasc Dis. 2015 Aug;9(4):217-37. doi: 10.1177/1753944715597623. Epub 2015 Aug 13.

引用本文的文献

1
Systemic Arterial Hypertension and Factors Associated with Blood Pressure Dysregulation in Companion Animals.伴侣动物的系统性动脉高血压及与血压调节异常相关的因素。
Vet Sci. 2025 May 9;12(5):453. doi: 10.3390/vetsci12050453.
2
Genome-wide association study identifying variants related to performance and injury in high-performance athletes.全基因组关联研究鉴定与高性能运动员表现和损伤相关的变异。
Exp Biol Med (Maywood). 2023 Oct;248(20):1799-1805. doi: 10.1177/15353702231198068. Epub 2023 Sep 26.
3
Mas receptor: a potential strategy in the management of ischemic cardiovascular diseases.

本文引用的文献

1
Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.Mas G 蛋白信号抑制可改善冠脉血流,减少心肌梗死面积,并提供长期心脏保护。
Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H299-311. doi: 10.1152/ajpheart.00723.2011. Epub 2011 Oct 14.
2
Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology.慢病毒介导的血管紧张素-(1-7)过表达减轻缺血诱导的心脏病理生理学改变。
Exp Physiol. 2011 Sep;96(9):863-74. doi: 10.1113/expphysiol.2011.056994. Epub 2011 Jun 17.
3
Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor.
Mas 受体:缺血性心血管疾病治疗的潜在策略。
Cell Cycle. 2023 Jul;22(13):1654-1674. doi: 10.1080/15384101.2023.2228089. Epub 2023 Jun 26.
4
Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy.血管紧张素 II 诱导的心肌肥厚信号转导机制。
Cells. 2022 Oct 22;11(21):3336. doi: 10.3390/cells11213336.
5
The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences.血管紧张素转换酶2/血管紧张素1-7轴在严重新型冠状病毒肺炎后果形成中的作用
Pharmaceutics. 2022 Sep 8;14(9):1906. doi: 10.3390/pharmaceutics14091906.
6
ACE2 pathway regulates thermogenesis and energy metabolism.ACE2 通路调节产热和能量代谢。
Elife. 2022 Jan 11;11:e72266. doi: 10.7554/eLife.72266.
7
Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy.SARS-CoV-2 与心肌细胞的相互作用:心脏损伤和药物治疗潜在分子机制的研究进展。
Biomed Pharmacother. 2022 Feb;146:112518. doi: 10.1016/j.biopha.2021.112518. Epub 2021 Dec 9.
8
COVID-19 and haemodynamic failure: a point of view on mechanisms and treatment.新冠病毒疾病与血流动力学衰竭:关于机制与治疗的观点
Anaesthesiol Intensive Ther. 2020;52(5):409-417. doi: 10.5114/ait.2020.101813.
9
Human induced pluripotent stem cells as a tool for disease modeling and drug screening for COVID-19.人类诱导多能干细胞作为COVID-19疾病建模和药物筛选的工具。
Genet Mol Biol. 2020 Nov 16;44(1 Suppl 1):e20200198. doi: 10.1590/1678-4685-GMB-2020-0198. eCollection 2020.
10
Angiotensin peptide synthesis and cyclic nucleotide modulation in sympathetic stellate ganglia.交感神经星状神经节中的血管紧张素肽合成与环核苷酸调节。
J Mol Cell Cardiol. 2020 Jan;138:234-243. doi: 10.1016/j.yjmcc.2019.11.157. Epub 2019 Dec 10.
血管紧张素 1-9 通过血管紧张素 2 型受体拮抗心肌细胞的促肥厚信号。
J Physiol. 2011 Feb 15;589(Pt 4):939-51. doi: 10.1113/jphysiol.2010.203075. Epub 2010 Dec 20.
4
Knockout of angiotensin 1-7 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II.血管紧张素 1-7 受体 Mas 敲除加重两肾一夹型 Goldblatt 高血压的病程:一氧化氮缺乏和血管对血管紧张素 II 反应性增强的作用。
Kidney Blood Press Res. 2010;33(6):476-88. doi: 10.1159/000320689. Epub 2010 Nov 10.
5
ACE2: more of Ang-(1-7) or less Ang II?ACE2:产生更多 Ang-(1-7) 还是更少 Ang II?
Curr Opin Nephrol Hypertens. 2011 Jan;20(1):1-6. doi: 10.1097/MNH.0b013e3283406f57.
6
The angiotensin AT2 receptor in left ventricular hypertrophy.左心室肥厚中的血管紧张素 AT2 受体。
J Hypertens. 2010 Sep;28 Suppl 1:S50-5. doi: 10.1097/01.hjh.0000388495.66330.63.
7
Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.血管紧张素转化酶 2 可抑制病理性心肌肥大、心肌纤维化和心功能障碍。
Circulation. 2010 Aug 17;122(7):717-28, 18 p following 728. doi: 10.1161/CIRCULATIONAHA.110.955369. Epub 2010 Aug 2.
8
Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1-7)-producing fusion protein in the heart.在心脏中携带产生血管紧张素 -(1 - 7)融合蛋白的转基因大鼠中,异丙肾上腺素诱导的心脏纤维化的减轻。
Ther Adv Cardiovasc Dis. 2010 Apr;4(2):83-96. doi: 10.1177/1753944709353426. Epub 2010 Jan 5.
9
Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.肾素-血管紧张素系统血管保护轴在心血管疾病中的治疗意义。
Hypertension. 2010 Feb;55(2):207-13. doi: 10.1161/HYPERTENSIONAHA.109.140145. Epub 2009 Dec 28.
10
Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.血管紧张素-(1-7) 通过一氧化氮/鸟苷 3',5'-环单磷酸依赖途径防止心肌细胞病理性重塑。
Hypertension. 2010 Jan;55(1):153-60. doi: 10.1161/HYPERTENSIONAHA.109.143255. Epub 2009 Dec 7.